fashion -WSS

fashion

author：entertainment 2025-10-02 19:39:10 - browse：453

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： UnitedHealth argues against case alleging wrongful AI care denials

WSS

Boston competes with Raleigh

Medicare drug price negotiation legal challenge met with skepticism

H5N1 virus can be tracked in retail milk, scientists say

Biogen walks away from Aduhelm, years after polarizing approval

Eyeing GLP

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Wikipedia

fashion

Wikipedia

Sports medicine is finally prioritizing gender equality

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Dobbs anniversary: the lost opportunity of abortion as health care

FTC sues over Novant Health acquisition of two N.C. hospitals

BioMarin wins approval for gene therapy to treat hemophilia A

Scrutiny of post

Hepatitis C has a cure — but many Americans still lack access to it

As a primary care physician, here's how I hope to partner with AI

After affirmative action ruling, medical educators look to 'holistic review'

Vertex non

focus

Biogen walks away from Aduhelm, years after polarizing approval

Cue Health, Covid

Fentanyl is making it harder to start addiction treatment

White House pharmacy plagued with problems, investigation finds

Cue Health, Covid

Why you shouldn’t ask, “What country has the best health care?”

hotspot

entertainment

explore

explore